[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
June 1997


Arch Surg. 1997;132(6):685. doi:10.1001/archsurg.1997.01430300127029

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The information given here is supplied by the companies cited. Publication of these notices does not imply endorsement or warranty by the American Medical Association, publishers of the Archives of Surgery.

THERAPEUTIC • Care-Tech® Laboratories, Inc, has introduced Humatrix® Microclysmic Gel, a new approach in the treatment of tissue trauma, third-degree burns, radiation irritation, mechanical injuries, laser peel, autograft, and chronic/acute wound therapy. Modifying endothermic properties of the tissue, Humatrix® Microcylsmic reduces surface temperatures 10° - 15° in the first 3 minutes' application. It is a non toxic OTC pharmaceutical that is bacteriostatic and modulates the osmotic pressure of a wound by timed release moisture, helping promote and accelerate cellular regeneration replicating the natural fibroconnective template and promoting fibroblast activity. Humatrix® contains chrondroitin sulfate and collagen. Humatrix® is also available in an 8.5-oz sprayer application. For more information, call Care-Tech® Customer Service at 800-325-9681. CARE-TECH® LABORATORIES, INC, 3224 S Kingshighway,

First Page Preview View Large
First page PDF preview
First page PDF preview